Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01682928 · ClinicalTrials.gov registry record · NA
Hydrotherapy for the Reversal of Oligohydramnios
A NA study, sponsored by Pediatrix.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01682928: Clinical Trial NA study, sponsored by Pediatrix.
NCT01682928 is a NA study that was terminated before completion, run by Pediatrix. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01682928, a NA study, was terminated before completion, sponsored by Pediatrix.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
OBJECTIVE: To assess the efficacy of subtotal immersion therapy as an option to improve maternal intravascular volume thereby improving both maternal and fetal hemodynamic status with reversal of oligohydramnios. This will be measured utilizing the Amniotic Fluid Volume (AFV) as the primary outcome. Secondary outcomes will be measured using Fetal Doppler Studies, Maternal vital signs (Blood Pressure, Pulse Pressure, Weight, Pulse) and input/output. HYPOTHESIS: Oligohydramnios, secondary to depleted maternal intravascular volume, can be reversed by improving feto- and uteroplacental perfusion with subtotal immersion therapy.
Primary Outcome
Subjects amniotic fluid index via ultrasound on days 3, 5 and 7 of study participation.
Interventions
- DRUG IV/Oral Hydration and Bedrest
- OTHER Hydrotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
Why NCT01682928 stopped before completion
NCT01682928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which IV/Oral Hydration and Bedrest is the first listed.
NCT01682928 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01682928 about?
NCT01682928 is a clinical study titled "Hydrotherapy for the Reversal of Oligohydramnios". OBJECTIVE: To assess the efficacy of subtotal immersion therapy as an option to improve maternal intravascular volume thereby improving both maternal and fetal hemodynamic status with reversal of oligohydramnios. This will be measured utilizing the Amniotic Fluid Volume (AFV) as the primary outcome....
What is the current status of trial NCT01682928?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2012-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01682928?
The interventions under investigation include: IV/Oral Hydration and Bedrest (DRUG), Hydrotherapy (OTHER).
Who is sponsoring clinical trial NCT01682928?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01682928's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia